Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Tirzepatide in recurrent hypertriglyceridemia-mediated pancreatitis and type 2 diabetes: a case report
Lechner B, Lechner K, Freibothe I, et al.
Cardiovascular diabetology. Endocrinology reports, 2026;12(1)
Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era
Mohamed ZI, Shidane AA, Abdiasis AM, et al.
Endocrinology, diabetes & metabolism;9(5):e70298
Effectiveness & safety of semaglutide in weight reduction in obese nondiabetic patients: A systematic review and meta-analysis
Naz F, Qaiser F, Mumtaz A, et al.
Medicine;105(31):e49986
[An historical overview of GLP-1/GIP incretins. From hormone to “swiss-army knife” medications]
Portha B
Biologie aujourd'hui, 2026;220(1-2):9-24
Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis
Pisani D, Lorenza D, Fordellone M, et al.
Endocrine, 2026;91(1)
Early changes in renal function do not appear to mediate cardiovascular risk with dapagliflozin plus semaglutide: a real-world observational hypothesis-generating cohort study
AlTaweel MO, Al Makhloof S, AlKhayyal AK, et al.
Expert review of cardiovascular therapy, 2026
Retatrutide effects on diabetic rats’ cognition
Ferreira J
Lab animal;55(8):287
Abrupt Smoking Cessation Due to Sensory Aversion Following Tirzepatide Initiation
Ceesay OI, Rokusek B, Rasmussen J, et al.
The primary care companion for CNS disorders, 2026;28(4)
Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity
Vishnoi S, Hudson S, Bhattacharya S, et al.
Journal of computer-aided molecular design, 2026;40(1)
Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis
Silverii GA, Velardi V, Marinelli C, et al.
Diabetes, obesity & metabolism, 2026
Incorporating estimands into meta-analyses of clinical trials
Remiro-Azócar A, Polavieja P, Boutmy E, et al.
Research synthesis methods, 2026;:1-28
Outpatient Dispensing Patterns and Changes in Tirzepatide Strength Mix in Japan: A Study Using the National Open Claims Data
Omura T, Kamihara T
Cureus, 2026;18(7):e113681
Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions
Alfonso Arvez MJ, Wade S, Goordeen D, et al.
Clinical pharmacology and therapeutics, 2026
Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists
Kopp KL, Lamberth K, Schelde O, et al.
Pharmaceutical research, 2026
Concurrent initiation of tirzepatide and biologics improves patient-reported outcomes in obese psoriatic arthritis: a propensity score-matched study
Venerito V, Lopalco G, Colaprico C, et al.
RMD open, 2026;12(3)
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial
Schacht JP, Sakai JT, Raymond K, et al.
The American journal of psychiatry, 2026;:appiajp20260003
PYY3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD
Geiger N, Nickel AG, Kohlhaas M, et al.
American journal of physiology. Endocrinology and metabolism, 2026
Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats
Vukoja I, Vlainic J, Francina M, et al.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2026;77(3):377-395
Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study
Lake JE, Kitch DW, Kantor A, et al.
HIV medicine, 2026
A Novel Microfluidic Strategy for the Fabrication of α-Lactalbumin Nanomicelles Paves a New Path for Antiobesity Technology
Bao C, Chen X, Fu J, et al.
Advanced healthcare materials, 2026;:e71486